Transdiagnostic Models and Treatments for Comorbid Anxiety and Emotional Disorders
- Date :
- Cet événement est passé.
- Type :
- Conférences et séminaires
- Public :
- S’adresse à tous les chercheurs, étudiants et professionnels de recherche
- Lieu :
- Centre de recherche du CHUSLocal 2999
Conférence du Centre de recherche du CHUS, organisée en collaboration avec l’axe Santé : populations, organisation et pratiques
Conférencier: Peter J. Norton, Ph.D.
Professor, School of Psychological Sciences
Director of Translational Research, Monash Institute of Clinical and Cognitive Neurosciences, Monash University, Melbourne, Australia
Recent research from a number of clinical trials has shown that Transdiagnostic Cognitive-Behavioral Therapy is efficacious, having shown comparable effects on primary anxiety disorder diagnoses as traditional diagnosis-specific CBT, and highly economical for treatment providers. However, a majority of anxiety disorder patients present with two or more “comorbid” diagnoses at once. An initial pilot study (Study 1) evaluated the effect of Transdiagnostic CBT on comorbid diagnoses of depression, suggesting that patients who present with both anxiety and depression show substantial improvements on both diagnoses. Study 2 compared the effect of Transdiagnostic CBT on treating comorbid diagnoses broadly, finding that Transdiagnostic CBT had greater effects on comorbid diagnoses than did diagnosis-specific CBT. Finally, new data (Study 3) examining the impact of Transdiagnostic CBT on comorbid anxiety-depression will be presented. Future directions for the treatment of complex comorbid anxiety and anxiety-depression will be discussed.
Conférence en anglais seulement
Un dîner sera servi pendant la conférence.
Disponible en visioconférence ou webex, composez 819 829-0084 option #5, option #3.